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Abstract
K-Mannosidosis is a lysosomal storage disorder caused by deficient activity of the lysosomal K-mannosidase. We report
here the sequencing and expression of the lysosomal K-mannosidase cDNA from normal and K-mannosidosis guinea pigs.
The amino acid sequence of the guinea pig enzyme displayed 82^85% identity to the lysosomal K-mannosidase in other
mammals. The cDNA of the K-mannosidosis guinea pig contained a missense mutation, 679CsT, leading to substitution of
arginine by tryptophan at amino acid position 227 (R227W). The R227W allele segregated with the K-mannosidosis genotype
in the guinea pig colony and introduction of R227W into the wild-type sequence eliminated the production of recombinant
K-mannosidase activity in heterologous expression studies. Furthermore, the guinea pig mutation has been found in human
patients. Our results strongly indicate that the 679CsT mutation causes K-mannosidosis and suggest that the guinea pig will
be an excellent model for investigation of pathogenesis and evaluation of therapeutic strategies for human K-
mannosidosis. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
K-Mannosidosis is a lysosomal storage disorder
caused by de¢cient activity of the lysosomal K-man-
nosidase (EC 3.2.1.24). This autosomal recessive en-
zyme de¢ciency leads to accumulation of mannose-
containing oligosaccharides in tissues and urine of
a¡ected individuals. The typical symptoms in human
patients include mental retardation, immunode¢-
ciency, hearing impairment and skeletal changes.
Common, but less consistent ¢ndings include lens
opacities, muscular hypotonia and hepatomegaly
[1]. As for most lysosomal storage disorder there is
a substantial variation in the degree of disease se-
verity among patients. Mapping of the mutational
spectrum in human patients has revealed more than
20 disease-causing mutations, but no apparent corre-
lation between the genotype and phenotype for K-
mannosidosis [2,3].
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K-Mannosidosis has been identi¢ed in several
breeds of cattle [4^8] and cats [9^12]. Both bovine
and feline K-mannosidosis are associated with severe
neurological impairment, but the disease severity
varies considerably between breeds. The disease-
causing mutations in these species appear to be
breed-speci¢c [7,13] and this may explain some of
the phenotypic heterogeneity between the breeds.
An K-mannosidosis mouse model was generated by
targeted disruption of the lysosomal K-mannosidase
gene. This model presents a histological and bio-
chemical phenotype that resembles the disease in hu-
mans and in the other animal models. At the clinical
level, however, no symptoms were observed in mice
followed up to the age of 12 months [14]. Although it
is possible that neurological and skeletal symptoms
may develop late in the mouse model, the apparent
lack of symptoms indicates that the murine model
represents a highly attenuated form of K-mannosido-
sis.
K-Mannosidosis was recently found to be the
cause of lysosomal storage disorder in a colony of
domestic guinea pigs [15]. The a¡ected guinea pigs
showed stunted growth, progressive mental dull-
ness, behavioral abnormalities and abnormal pos-
ture and gait. Histological examination revealed
widespread vacuolation throughout the central
nervous system and visceral organs, together with
mild skeletal abnormalities. Furthermore, thin layer
chromatography [15] and tandem mass spectrome-
try (T. Berg, unpublished results) indicated the oli-
gosaccharides accumulating in the guinea pig were
identical to those accumulating in human patients.
Since the clinical, histological and biochemical ¢nd-
ings indicated that guinea pig K-mannosidosis
closely resembles the human disease, a colony of
K-mannosidosis guinea pigs has been established
in order to evaluate di¡erent therapeutic strategies
for lysosomal storage disorders. As a step towards
development of therapy, and to characterize guinea
pig K-mannosidosis at the molecular level, we have
cloned and expressed the guinea pig lysosomal K-
mannosidase gene, identi¢ed the mutation causing
K-mannosidosis in the colony and expressed the
mutant protein.
2. Materials and methods
2.1. Sequencing of guinea pig lysosomal K-
mannosidase cDNA
RNA was prepared from cultured guinea pig ¢bro-
blasts using the Trizol reagent (Gibco-BRL) and re-
verse transcribed by Superscript II reverse transcrip-
tase (Gibco-BRL). PCRs were performed using
Takara EX-Taq polymerase (TaKaRa Shuzo Corp.)
in the supplied bu¡ers added 200 nM of dNTPs and
0.2 WM of each primer (Table 1). Typically, 35 cycles
were performed with 5 min initial denaturation at
94‡C, followed by cycling with 30 s at annealing
temperature (Table 1), 1^3 min extension at 72‡C
and 20 s denaturation at 98‡C. The primers for the
two initial PCRs (fragments 1 and 2, Table 1) were
derived from bovine and human K-mannosidase se-
quences and were located to conserved regions of the
K-mannosidase gene. These two fragments covered
about 80% of the coding region of the guinea pig
K-mannosidase cDNA as determined by comparison
to the K-mannosidase cDNA sequences of other spe-
cies. The 5P and 3P regions of the K-mannosidase
cDNA are not very well conserved between species
and none of the available primers worked on the
guinea pig cDNA in these regions. A ‘genomic walk-
ing’ strategy was therefore chosen to isolate these
regions. The guinea pig genomic DNA library was
constructed using reagents supplied in the ‘Promoter
¢nder’ kit (Clontech) and the relevant sequence am-
pli¢ed by PCR using adaptor-speci¢c primers in
combination with gene-speci¢c primers as described
by the supplier. The 5P sequence was obtained in two
steps where the ¢rst (fragment 6, Table 1) resulted in
around 700 bp of sequence starting from what we
predicted to be in intron 2. A subsequent step (frag-
ment 7, Table 1) gave the sequence of exon 1 con-
taining a potential start codon and around 300 bp of
genomic sequence upstream of this ATG. A 500 bp
fragment containing the 3P part of the gene was ob-
tained in PCR fragment 8 (Table 1). Based on these
5P and 3P genomic sequences, a forward primer up-
stream of the putative start codon and a reverse
primer downstream the stop codon was designed.
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These two primers were used to generate PCR frag-
ments 3 and 4 (Table 1), which in combination with
fragments 1 and 2 (Table 1) covered coding region of
the guinea pig K-mannosidase cDNA. All PCR prod-
ucts were sequenced on both strands using Big Dye
dideoxy terminator chemistry (Applied Biosystems)
with separation and detection of the termination
products on an automatic sequencer (Applied Biosys-
tems). Computer sequence analysis was performed
using the GCG program package version 8 (Genetics
Computer Group).
2.2. Mutational screening
PCR fragments 1^4 (Table 1) covering the coding
region of the K-mannosidase gene were generated
from cDNA prepared from ¢broblasts of an a¡ected
guinea pig. The sequences of these PCR products
were aligned to the normal sequence. To develop a
DNA based screening assay for the 679CsT muta-
tion (R227W), the £anking DNA sequence was de-
termined by amplifying and sequencing the upstream
intron (fragment 9, Table 1). Based on this sequence
an intronic primer, mpgimutF, was designed and
used in combination with primer mpgmutR to am-
plify the mutation-containing region from blood
spots collected on ¢lter paper. Brie£y, a 3-mm disc
was punched from ‘Guthrie card’ ¢lter paper and
soaked in 90 Wl 1U PCR bu¡er (Boehringer Mann-
heim) for 30 min at 4‡C then 99‡C for 15 min. Fol-
lowing this pre-treatment of the template, 10 Wl 1U
PCR bu¡er with 5 U Taq polymerase (Boehringer
Mannheim), dNTPs and primers were added and
the reaction cycled 40 times (fragment 10, Table 1).
An AciI recognition site is abolished due to the
679CsT transition. Normal and mutant alleles
could be therefore be distinguished by AciI digestion
of the PCR product followed by agarose gel electro-
phoresis.
2.3. Expression of normal and mutant K-mannosidase
in COS-7 cells
PCR fragment 5 (Table 1), which covered the cod-
ing region of the K-mannosidase cDNA sequence,
was cloned into a pcDNA3.1 based TOPO cloning
vector (Invitrogen). QuickChange PCR based muta-
genesis system (Stratagene) was used to generate a
plasmid containing the 679CsT mutation
(R227W). The expression plasmids were puri¢ed us-
ing the Concert midi-prep system (Life Technologies
DNA) and the K-mannosidase cDNA insert se-
quenced. COS-7 cells were transfected in six-well cul-
ture plates using 1 Wg DNA mixed to 6 Wl FuGENE
reagent (Boehringer Mannheim) per well as described
by the supplier. After 48 h incubation in culture me-
dium containing 1% (v/v) bovine serum, the medium
was harvested and centrifuged. Cells were harvested
by trypsination, washed two times in culture medium
with 10% (v/v) bovine serum, then once in PBS be-
fore resuspending the cell pellet in 50 Wl PBS con-
taining 0.1% (v/v) Triton X-100. The cells were lysed
by incubation at 4‡C for 1 h followed by three cycles
of freeze^thawing. The K-mannosidase activity of
cells and culture medium was assayed in 0.1 M so-
dium phosphate bu¡er with 4 mM 4-methylumbelli-
feryl-K-mannopyranoside at pH 4.5 [18]. One unit of
activity is de¢ned as the amount of enzyme liberating
1 Wmol 4-methylumbelliferyl per min at 37‡C. Pro-
tein concentration was determined by BCA methods
(Bio-Rad).
3. Results
3.1. Characterization of the guinea pig lysosomal K-
mannosidase cDNA
The cDNA sequence of guinea pig lysosomal K-
mannosidase were assembled from four overlapping
PCR products and contained an open reading frame
of 1008 codons (Fig. 1A). The cDNA sequencing
revealed that the normal guinea pig analyzed in
this study was heterozygous at three nucleotide posi-
tions. Two C/T variants, 2397C/T (codon 799) and
2629C/T (codon 843), were silent. The third variant,
165G/C, resulted in either a methionine or an isoleu-
cine at codon 55. The sequence alignment revealed
that this amino acid residue is not conserved between
species (Fig. 1B). Computer predictions indicated
that the signal sequence cleavage site of guinea pig
K-mannosidase is located at the same position as the
cleavage site experimentally de¢ned for human
[16,17], bovine [18] and feline [13] K-mannosidase.
The amino acid sequence of guinea pig K-mannosi-
dase displays 82^85% identity to the lysosomal
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K-mannosidases cloned from other mammalian spe-
cies (man, mouse, cat and cattle).
3.2. Mutation detection in K-mannosidosis guinea pigs
Sequencing of the coding region of the K-manno-
sidase cDNA from an a¡ected guinea pig revealed a
unique C to T transition at nucleotide position 679
(Fig. 2). This 679CsT mutation resulted in substi-
tution of arginine in position 227 with tryptophan
(R227W). The R227 residue is conserved in all lyso-
somal K-mannosidase cloned to date (Fig. 1B). Guin-
ea pig DNA was screened for the presence of the
679CsT mutation by using an assay that involved
PCR ampli¢cation of the exon containing the muta-
tion followed by AciI digestion. This revealed that all
the obligate carriers in the K-mannosidosis guinea
pig colony, including the two founders of the colony,
were heterozygous for the 679CsT mutation (Fig.
2). Furthermore, all a¡ected animals were homozy-
gous for 679CsT. Subsequent testing of more than
100 animals from the colony has shown that
679CsT segregate with K-mannosidosis in the col-
ony (results not shown).
3.3. Expression studies of normal and mutant K-
mannosidase cDNA
Expression vectors containing the normal and
R227W mutant cDNA sequences were transfected
Table 1
Oligonucleotides used for PCR ampli¢cation of the guinea pig lysosomal K-mannosidase gene
PCR fragment Annealing temp. (‡C) Primer combinationa Primer sequence (5P to 3P)b
1 56 mph263F 503-ACCAGATGCCACTTGGGCT
mp3R 2330-CGGCCATTGCTGTCAGTGTAGAA
2 58 mp306F 1953-GGTGCCTACATCTTCAGAC
mp2R 2996-GCCAGCAAGGTACGGATTTCCAT
3 58 mpg5UT2F -44-ATCCGGGCCCGGGAACACCCTGGA
mpg4R 593-TGGCCAAAGGGGTCAATATGCCA
4 66 mp306F (see PCR fragment 2)
mpg3UT2R 3062-GCTGGCCCCACATCTGGAGCA
5 66 mpg5UT2F (see PCR fragment 3)
mpg5UT2R (see PCR fragment 4)
6a 64 AP-1 GTAATACGACTCACTATAGGGC
mpg4R (see PCR fragment 3)
6b 64 AP-2 ACTATAGGGCACGCGTGGT
mpg3R GTGGGCGCCCGTCACTGCCAA
7a 64 AP-1 (see PCR fragment 6a)
mpgi2R CCGCTGGCAGAGCCCCACGCT
7b 64 AP-2 (see PCR fragment 6b)
mpgi1R CGTCCCACAGCTAAAGGAACGCAT
8a 64 mpg5F 2911-CCCATCTCCCGCCCTGCTGTG
AP-1 (see PCR fragment 6a)
8b 64 mpg6F 2939-CCAGGCTGGACCCCTCCTCCA
AP-2 (see PCR fragment 6b)
9 60 mph263F (see PCR fragment 1)
mpgmutR 756-AGTGAAGAGGTCGGCCGCAG
10 52 mpgimutF ATGGGCTTTGATGGTGTCT
mpgmutR (see PCR #9)
11c 50 mpgR227W-F 667-GATAAACTGGTGTGGAAGAAGAGACGGGAGATGG
mpgR227W-R 700-CCATCTCCCGTCTCTTCTTCCACACCAGTTTATC
amp, mph, mpg were primers derived for the bovine, human and guinea pig cDNA sequence, respectively. The mpgi primers are com-
plementary to intronic sequences of the guinea pig gene. AP-1 and AP-2 were provided in the Genomic Walking kit from Clontech.
bThe number before the primer sequence shows the position of the 5P nucleotide. The underlined positions of the mp and mph prim-
ers indicate mismatches to the guinea pig sequence.
cPCR 11 shows the site-speci¢c mutagenesis PCR to introduce the 679CsT mutation (R227W) to the wild-type expression construct.
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Fig. 1. (A) The sequence of lysosomal K-mannosidase from the guinea pig. An arrow indicates the predicted position of the signal se-
quence cleavage site. The positions of the 165G/C (M/I55), 679CsT (R227W), 2397T/C and 2629T/C variants are underlined with
the alternative nucleotide shown above the sequence. Potential N-glycosylation sites are boxed in black. (B) Sequence alignments of ly-
sosomal K-mannosidase showing the regions containing the M/I55 variant found in normal guinea pigs (left alignment) and the
R227W substitution in K-mannosidosis guinea pigs (right alignment). Positions corresponding to guinea pig M55 and R227 are boxed,
whereas shadowed residues indicate positions that are identical to the guinea pig sequence. Gaps introduced to optimize the alignment
are shown by dots and the GenBank accession numbers in parentheses.
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into COS-7 cells (Table 2). A signi¢cant increase in
the K-mannosidase activity both in cells and medium
was detected following transfection with this wild-
type construct compared to the negative control. In
contrast, no increase in activity was detected in cells
transfected with a cDNA encoding R227W substi-
tuted K-mannosidase. A construct containing the
wild-type cDNA with a methionine codon in position
55 and hence representing the M55 allele detected in
a normal guinea pig, expressed K-mannosidase to
similar levels as the wild-type construct with the
I55 allele (results not shown). This indicated that
the polymorphic site at residue 55 represents an ami-
no acid polymorphism that does not a¡ect the ex-
pression levels.
4. Discussion
In the present paper, we describe the cloning of the
guinea pig lysosomal K-mannosidase cDNA sequence
and identi¢cation of the 679CsT (R227W) muta-
tion in guinea pig K-mannosidosis, which demon-
strates the quite similar clinical presentations of
those of human K-mannosidosis.
The authenticity of the cloned cDNA from guinea
pigs was con¢rmed by the high degree of sequence
similarity to the cDNA sequences of lysosomal K-
mannosidase from other species. Furthermore, trans-
fection of COS-7 cells by the cDNA sequence re-
sulted in a signi¢cant increase in intra- and extracel-
lular K-mannosidase activity, and ¢nally, we were
able to demonstrate that this cDNA sequence was
mutated in guinea pigs de¢cient in the lysosomal K-
mannosidase.
There are several lines of evidence strongly indicat-
ing that the mutation 679CsT (R227W) identi¢ed
in K-mannosidosis guinea pigs causes disease. First,
the mutation segregated with the K-mannosidosis
genotype as determined from pedigree analysis of
the guinea pig colony. Second, the a¡ected residue,
R227, represents a conserved amino acid position.
Third, site-speci¢c mutagenesis showed that R227W
substitution of the wild-type K-mannosidase abol-
ished the production of recombinant K-mannosidase
activity in a mammalian expression system (COS-7
Fig. 2. Detection of the 679CsT mutation (R227W) in K-mannosidosis guinea pigs. (Left) 679CsT as identi¢ed by sequencing the
cDNA from an a¡ected guinea pig. (Right) Agarose gel electrophoresis of AciI digested PCR products. Lane 1 shows undigested
PCR product; lanes 2^13 digested PCR products from obligate carriers (lanes 2^5), a¡ected (lanes 6^10), and normal animals (lanes
11^13). The carriers in lanes 2 and 3 represent the two founders of the colony.
Table 2
Transient expression of lysosomal K-mannosidase cDNA in COS-7 cells
cDNA Activity
Medium (nmol min31 ml31) Cell lysate (nmol min31 mg31)
Wild-type 11.16 þ 3.02 8.58 þ 0.40
Wild-type reverse orientation 5.47 þ 0.43 3.32 þ 0.07
R227W mutant 5.07 þ 0.59 3.13 þ 0.08
COS-7 cells were transfected with pcDNA3.1 vector containing the normal lysosomal cDNA sequence in forward orientation or re-
verse orientation (negative control), or containing the 679CsT (R227W) mutation. Results are expressed as means (n = 3) þ S.D.
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cells). Fourth, a mutation identical to the guinea pig
679CsT mutation has been identi¢ed in three hu-
man K-mannosidosis patients (Ò. Nilssen, personal
communication). The corresponding substitution in
the human K-mannosidase sequence is R229W be-
cause the human sequence contains an insertion of
two amino acids in the signal sequence compared to
the guinea pig sequence. Both the human and the
guinea pig mutation involve a C to T change in a
CpG dinucleotide. This is also the case for the most
common mutation in humans, the R750W substitu-
tion, which accounts for approximately 21% of the
mutant alleles [3]. The CpG dinucleotides are prone
to mutations through a mutational mechanism
known as methylation-mediated deamination of 5P-
methylcytosine [19]. Most probably, the mutation of
the R227W allele in guinea pigs, as well as the mu-
tations of the R229W and R750W alleles in humans
were generated by this mechanism. The three human
patients that carry the R229W allele are compound
heterozygous; one patient carries R229W in combi-
nation with the frequent R750W allele, whereas two
siblings in carry the R229W allele in combination
with a splicing mutation (Ò. Nilssen, personal com-
munication).
Guinea pig K-mannosidosis mirrors human K-
mannosidosis with respect to histology and the na-
ture of the storage products. Furthermore, K-manno-
sidosis in the guinea pig is associated with distinct
neurological and skeletal symptoms commonly found
in human patients [15]. This is in contrast to the
mouse ‘knock-out’ model where no clinical symp-
toms were evident in mice studied up to the age of
12 months [14]. The reason for the highly attenuated
phenotype in the mouse compared to other animal
models is not clear. Possibly, the types of oligosac-
charides accumulating or the rate of accumulation
may di¡er in the mouse compared to the other ani-
mal models. For some other lysosomal storage dis-
eases, such as Tay^Sachs disease, it was found that a
metabolic bypass resulted in an almost normal phe-
notype in the mouse model [20,21]. In the case of
K-mannosidosis, one can speculate that alternative
K-mannosidase activities could be involved in such
metabolic bypass e¡ects.
The guinea pig model represents a thoroughly
studied and convenient animal model that should
be well suited for monitoring the clinical e¡ects of
di¡erent therapeutic protocols for K-mannosidosis.
We have initiated studies aimed at determining the
e⁄cacy of enzyme replacement therapy as well as
transplantation of genetically engineered stem cells
of the central nervous system. Previous studies of
enzyme replacement therapy for lysosomal storage
have indicated better long-term e¡ects from using
the same-species enzyme as opposed to using enzyme
from another species, i.e., using enzyme of human
origin in animal models [22]. The cloning of the guin-
ea pig K-mannosidase cDNA makes developing of
species-speci¢c gene and enzyme replacement thera-
pies for the guinea pig model possible. Furthermore,
our ¢nding that the guinea pig K-mannosidosis mu-
tation is identical to a human mutation adds further
support to make the guinea pig an appropriate mod-
el for evaluation of therapeutic protocols for lysoso-
mal storage disorder. Finally, the identi¢cation of the
guinea pig mutation enabled us to develop a DNA
based assay that has been most important in manag-
ing a breeding program for the K-mannosidosis col-
ony.
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